Is eFFECTOR Therapeutics, Inc. (EFTR) a Buy, Sell, or Hold?
OTC : EFTR
eFFECTOR Therapeutics, Inc. — Institutional Ownership
$0.0002 USD
$0 (0.0%)
- Volume
- 331
- Average Volume
- 1.67K
- Market Capitalization
- $941
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.77
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-03-07 | Altitude Life Science Ventures Side Fund II, L.P. | 1.41M | 3.40% |
| 2023-03-07 | Altitude Life Science Ventures Fund II, L.P. | 1.41M | 3.40% |
| 2023-03-07 | David Maki | 2.83M | 6.70% |
| 2023-03-07 | Altitude Life Science Ventures II, LLC | 2.83M | 6.70% |
| 2022-08-11 | Carlyle Holdings I GP Inc. | 4.83M | 11.70% |
| 2022-08-11 | Carlyle Genesis UK LLC | 4.83M | 11.70% |
| 2022-08-11 | Abingworth LLP | 4.83M | 11.70% |
| 2022-08-11 | Carlyle Investment Management L.L.C. | 4.83M | 11.70% |
| 2022-08-11 | The Carlyle Group Inc. | 4.83M | 11.70% |
| 2022-08-11 | TC Group, L.L.C. | 4.83M | 11.70% |
| 2022-08-11 | Carlyle Holdings I L.P. | 4.83M | 11.70% |
| 2022-08-11 | Abingworth Bioventures VI LP | 4.83M | 11.70% |
| 2022-08-11 | CG Subsidiary Holdings L.L.C. | 4.83M | 11.70% |
| 2022-08-11 | Carlyle Holdings I GP Sub L.L.C. | 4.83M | 11.70% |
| 2022-02-14 | ( 82-5524518 | 365.04K | 0.90% |
| 2022-02-14 | ( 13-5315170 | 2.24M | 5.56% |
| 2022-02-14 | ( 81-4343957 | 1.88M | 4.65% |
| 2022-02-11 | Fund III, L.P | 2.38M | 5.90% |
| 2022-02-11 | Sectoral Asset Management Inc. | 2.38M | 5.90% |
| 2022-02-11 | Jérôme G. Pfund | 2.38M | 5.90% |
| 2022-02-14 | SR One Capital Fund I Aggregator, LP | 4.82M | 11.90% |
| 2022-02-14 | SR One Co-Invest Manager I, LLC | 2M | 5.00% |
| 2022-02-11 | Michael L. Sjöström | 2.38M | 5.90% |
| 2022-02-14 | SR One Capital Management, LLC | 6.82M | 16.90% |
| 2022-02-14 | SR One Co-Invest I, LLC | 2M | 5.00% |
| 2022-02-14 | Simeon George | 6.82M | 16.90% |
| 2022-02-14 | SR One Capital Partners I, LP | 4.82M | 11.90% |
| 2021-09-13 | U.S. Venture Partners X, L.P. (“USVP X”) | 4.67M | 11.50% |
| 2021-09-13 | Presidio Management Group X, L.L.C. (“PMG X”) | 4.82M | 11.90% |
| 2021-09-13 | Casey M. Tansey | 4.82M | 11.90% |
| 2021-09-13 | USVP X Affiliates, L.P. (“AFF X”) | 149.49K | 0.40% |
| 2021-09-13 | Jonathan D. Root | 4.82M | 11.90% |
| 2021-09-07 | The Column Group II GP, LP | 4.31M | 10.60% |
| 2021-09-07 | David Goeddel | 4.31M | 10.60% |
| 2021-09-07 | The Column Group II, LP | 4.31M | 10.60% |
| 2021-09-07 | Peter Svennilson | 4.31M | 10.60% |
| 2021-08-25 | Feis Equities LLC | - | 0.00% |
| 2021-08-25 | Lawrence M. Feis | - | 0.00% |
| 2021-08-20 | Beryl Capital Management LP | - | 11.00% |
| 2021-08-20 | Beryl Capital Partners II LP | 1.07M | 11.00% |
| 2021-08-20 | Beryl Capital Management LLC | 1.26M | 11.00% |
| 2021-08-20 | David A. Witkin | 1.26M | 11.00% |
| 2021-08-17 | Lawrence M. Feis | 906.66K | 5.02% |
| 2021-02-08 | WONG | 928.09K | 5.10% |
| 2021-02-08 | LP | 928.09K | 5.10% |
| 2021-02-08 | LINDEN CAPITAL L.P. | 855.84K | 4.70% |
| 2021-02-08 | LLC | 855.84K | 4.70% |
| 2021-01-21 | Empyrean Capital Partners, LP | 1M | 5.50% |
| 2021-01-21 | Amos Meron | 1M | 5.50% |
| 2021-01-21 | Empyrean Capital Overseas Master Fund, Ltd. | 1M | 5.50% |
EFTR Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $11.69 | 2.19M | $25.57M | $14.88M | $20.54M | $31.24M |
| 2022-12-31 | $10.69 | 1.65M | $17.61M | $8.71M | $20.28M | $29.18M |
| 2021-12-31 | $207.00 | 1.62M | $334.43M | $49.7M | $20.03M | $304.76M |
| 2020-12-31 | $248.75 | 598.56K | $148.89M | $15.22M | $12.96M | $146.64M |
| 2019-12-31 | $248.75 | 55166 | $13.72M | $3.43M | $15.24M | $25.54M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-03-31 | $15.67 | 2.67M | $41.84M | $15.51M | $20.25M | $46.58M |
| 2023-12-31 | $11.69 | 2.67M | $31.21M | $14.88M | $20.54M | $36.88M |
| 2023-09-30 | $15.00 | 2.47M | $37.06M | $5.39M | $20.48M | $52.15M |
| 2023-06-30 | $20.76 | 1.91M | $39.72M | $14.71M | $20.41M | $45.41M |
| 2023-03-31 | $8.82 | 1.68M | $14.82M | $10.31M | $20.35M | $24.85M |
| 2022-12-31 | $10.69 | 1.66M | $17.78M | $8.71M | $20.28M | $29.35M |
| 2022-09-30 | $14.30 | 1.65M | $23.55M | $11.9M | $20.22M | $31.86M |
| 2022-06-30 | $35.50 | 1.64M | $58.39M | $16.35M | $20.15M | $62.19M |
| 2022-03-31 | $100.25 | 1.74M | $173.96M | $17.66M | $20.07M | $176.37M |
| 2021-12-31 | $207.00 | 1.62M | $334.43M | $49.7M | $20.03M | $304.76M |
| 2021-09-30 | $351.25 | 1.61M | $567.19M | $54.77M | $19.79M | $532.21M |
| 2021-06-30 | $247.25 | 902.25K | $223.08M | $10.88M | $19.72M | $231.92M |